CASI Pharmaceuticals, Inc. to Participate in Two Upcoming September Conferences

Rhea-AI Summary

CASI Pharmaceuticals has announced that its CEO, Dr. Wei-Wu He, will present at two virtual conferences in September 2020. The H.C. Wainwright 22nd Annual Global Investment Conference is scheduled for September 14 at 12:30 PM EDT, followed by the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 23 at 1:40 PM EDT. Webcasts will be accessible on the company's website, with archived replays available for 90 days. CASI Pharmaceuticals focuses on innovative therapeutics, especially in hematology and oncology in China and the U.S.

ROCKVILLE, Md. and BEIJING, Sept. 11, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announced that Dr. Wei-Wu He, Chairman and Chief Executive Officer of CASI Pharmaceuticals, will be presenting at the following upcoming virtual conferences in September. Details for the virtual conferences are as follows.

H.C. Wainwright 22^nd Annual Global Investment Conference
Date: Monday, September 14th
Time: 12:30 PM (EDT)

Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Date: Wednesday, September 23^rd
Time: 1:40 PM (EDT)

Webcast or external link of the company presentations will be available under "Events & Presentations" in the "Investors Relations" section of CASI's website. Archived replays will be available for approximately 90 days following the event.

About CASI Pharmaceuticals

CASI Pharmaceuticals, Inc. ("CASI" or the "Company") is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. The Company intends to execute its plan to become a leader by launching medicines in the greater China market leveraging the Company's China-based regulatory and commercial competencies and its global drug development expertise. The Company's operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals (China) Co., Ltd. ("CASI China"), which is located in Beijing, China. The Company has built a commercial team of over 70 hematology and oncology sales and marketing specialists based in China. More information on CASI is available at www.casipharmaceuticals.com.

COMPANY CONTACT: CASI Pharmaceuticals, Inc. 240.864.2643 ir@casipharmaceuticals.com

INVESTOR CONTACT: Solebury Trout Jennifer Porcelli 646.378.2962 jporcelli@troutgroup.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/casi-pharmaceuticals-inc-to-participate-in-two-upcoming-september-conferences-301128032.html

SOURCE CASI Pharmaceuticals, Inc.

FAQ

What are the dates and times for CASI's September 2020 conference presentations?

CASI Pharmaceuticals will present at the H.C. Wainwright conference on September 14 at 12:30 PM EDT and at the Oppenheimer Summit on September 23 at 1:40 PM EDT.

Where can I watch CASI's conference presentations?

Webcasts of CASI Pharmaceuticals' presentations will be available in the 'Events & Presentations' section of their website.

How long will CASI's conference presentations be available for replay?

The archived replays of CASI Pharmaceuticals' conference presentations will be available for approximately 90 days following each event.

Who is presenting for CASI Pharmaceuticals at the conferences?

Dr. Wei-Wu He, the Chairman and CEO of CASI Pharmaceuticals, will be presenting at the upcoming conferences.